✦ LIBER ✦

Drug therapy: Sorafenib

✍ Scribed by Richard S. Finn

Book ID: 102242402
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 233 KB
Volume: 51
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23676

No coin nor oath required. For personal study only.

✦ Synopsis

He is on the speakers' bureau of Genentech. He received grants from Bristol-Myers Squibb and Novartis. He is a consultant for and received grants from Bayer.

📜 SIMILAR VOLUMES

Keratoacanthomas associated with sorafen

Keratoacanthomas associated with sorafenib therapy

✍ Heidi H. Kong; Edward W. Cowen; Nilofer S. Azad; William Dahut; Martin Gutierrez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Systemic targeted therapy beyond sorafen

Systemic targeted therapy beyond sorafenib

✍ Cabrera, Roniel 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 451 KB

Drug-related adverse events may predict

✍ Yan Zhao; Man Yang; Xingshun Qi; Guohong Han; Daiming Fan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Sorafenib in der Therapie des fortgeschr

Sorafenib in der Therapie des fortgeschrittenen Nierenzellkarzinoms

✍ C. Doehn; H.-D. Peters 📂 Article 📅 2006 🏛 Springer 🌐 German ⚖ 923 KB

Komplette Thrombusregression nach Sorafe

Komplette Thrombusregression nach Sorafenib-Therapie bei Nierenzellkarzinom mit Cavathrombus

✍ M. Siedler; M. Beissert; E. Marques-Maggio; N. Papoutsoglou; A. Loeser; H. Riedm 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 German ⚖ 662 KB

Sorafenib therapy in advanced hepatocell

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial

✍ Rimassa, Lorenza ;Santoro, Armando 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 291 KB